General
Alzheimer’s drug Lecanemab approved by Therapeutic Goods Administration for use in Australia
A promising new Alzheimer’s drug has been green-lit by the national medicines regulator, after two previous failed attempts to register it for use in Australia.
Lecanemab, sold under the brand name Leqembi, has been shown to clear amyloid plaque in the brain, which experts believe plays a role in…
Continue Reading
-
Noosa News13 hours agoSunshine Coast shines in tourism awards
-
Noosa News22 hours agoCorey Rocchiccioli stars as WA beats Queensland in one-wicket Sheffield Shield thriller
-
General23 hours agoMore than 11,000 homes lose power as storms with spectacular lightning hit south-east Queensland
-
General14 hours agoNational tax regulator shuts down Coolah firm and bans director after large-scale theft